Suven Life Sciences Ltd Net Loss is INR -24.39 crores in Quarter 3, October – December of Financial Year 2020-2021.
Quarterly Net Earnings Year-on-Year
Suven Life Sciences Ltd Quarter Net Loss is narrowed by 7 % from Last Year Quarter and Net Loss of INR -24.39 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Loss was INR -22.81 crores.
Quarterly Net Sales Year-on-Year
Suven Life Sciences Ltd Quarter Sale is down -45 % from Last Year Quarter.
Annual Sales & Net Earning
Suven Life Sciences Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 285.67 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR -23.9 crores.
Suven Life Sciences Ltd Stock Information
|Industry||Pharmaceuticals – Indian – Bulk Drugs|
|About||Suven Life Sciences is engaged in providing building blocks (bulk actives, drug intermediates and speciality chemicals) for global life science companies.|
|Latest Qaurter EPS||-1.91621021794132|
Suven Life Sciences Ltd Stock Analysis: